The traditional process of drug discovery and development is often slow, costly, and fraught with challenges. At Amrit, we believe that by providing rapid and easy access to comprehensive real-world data, we can help researchers and pharmaceutical companies overcome these challenges. Our goal is to significantly reduce the time it takes to bring new treatments to market, thereby improving patient care and saving lives. Along this journey, we collaborate with data owners by offering transparent and unparalleled incentive models.
Amrit aspires to become the largest and most comprehensive repository of real-world health data outside the United States. Our vision is to integrate multimodal data, including radiology, pathology, genomics, electronic health records, and patient-reported outcomes (PROs) into a cohesive platform that can be accessed and utilized by healthcare professionals, researchers, and pharmaceutical companies worldwide. By achieving this, we aim to significantly accelerate the pace of drug discovery and development, ultimately improving outcomes for patients globally.
Amrit is committed to making real-world health data readily available and easily accessible to researchers and clinicians. Our platform will enable users to access critical data at unprecedented speed, facilitating quicker decisions in clinical trials and drug development. Additionally, we aim to provide robust recruitment support for clinical trials, ensuring that the right patients are quickly matched with the right studies, thereby reducing the time and cost associated with bringing new treatments to market.
Partnerships with Clinics and Hospitals: .We collaborate with leading clinics and hospitals around the globe to ensure that our data is comprehensive, accurate, and up to date. These partnerships allow us to gather a wide range of health data, including clinical, imaging, and genomic data.
Utilizing AI and Blockchain Technology: By leveraging AI and blockchain, we ensure that our data is not only comprehensive but also secure and reliable. AI enables us to process and analyze data rapidly, while blockchain guarantees the integrity and traceability of our data.
Utilizing Large Language Models (LLMs): Amrit incorporates state-of-the-art large language models, such as Llama 3 and Nemotron, into all AI-related processes. These models enable advanced data processing, natural language understanding, and predictive analytics, ensuring that our insights are accurate, actionable, and delivered swiftly. The use of LLMs allows us to enhance our AI capabilities, providing our clients with the most sophisticated tools for their research and development needs.
Molecular Cancer: Molecular oncology data
Amrit is equipped with one of the largest computational infrastructures in the industry, capable of processing massive volumes of data, including radiology, pathology, and other complex data types. Our cutting-edge computational power enables us to offer unmatched speed and efficiency in data processing, making us the partner of choice for organizations looking to leverage big data for drug development and clinical trials. We are well-prepared to assist data owners, clinics, and hospitals in maximizing their revenues by structuring, centralizing, and licensing their health data.
